These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 733865)

  • 1. Effect of acetylsalicylic acid, sulfinpyrazone and their combination on collagen-induced platelet aggregation in guinea pigs.
    Wong LT; Zawidzka Z; Thomas BH
    Pharmacol Res Commun; 1978 Nov; 10(10):939-49. PubMed ID: 733865
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effects of heparin, sulfinpyrazone and acetylsalicylic acid on the collagen-induced thromboyte aggregation].
    Haas S; Fritsche HM; Ketterl R; Leimgruber D; Blümel G
    Med Welt; 1979 Jun; 30(22):862-7. PubMed ID: 440074
    [No Abstract]   [Full Text] [Related]  

  • 3. The prolonged effect of sulfinpyrazone on collagen-induced platelet aggregation in vivo.
    Buchanan MR; Rosenfeld J; Hirsh J
    Thromb Res; 1978 Nov; 13(5):883-92. PubMed ID: 741458
    [No Abstract]   [Full Text] [Related]  

  • 4. [Influence of Anturane on platelets aggregation. Comparative study with acetylsalicylic acid in patients with and without oral anticoagulant therapy].
    Fernández B de Quirós J; Dulp-Gollasch I; Hess H
    Rev Clin Esp; 1978 Nov; 151(3):219-22. PubMed ID: 740996
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of platelet adhesion to rabbit aorta by sulphinpyrazone and acetylsalicylic acid.
    Essien EM; Mustard JF
    Atherosclerosis; 1977 May; 27(1):89-95. PubMed ID: 856231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A metabolite of sulphinpyrazone that is largely responsible for the effect of the drug on the platelet prostaglandin pathway.
    Pay GF; Wallis RB; Zelaschi D
    Biochem Soc Trans; 1980 Dec; 8(6):727-8. PubMed ID: 7461266
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of sulfinpyrazone on enhanced platelet aggregation in vitro (author's transl)].
    Walter E; Weber E
    Arzneimittelforschung; 1978; 28(10):1778-81. PubMed ID: 582683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acetylsalicylic acid, sulfinpyrazone and dipyridamole on platelet adhesion and aggregation in flowing native and anticoagulated blood.
    Baumgartner HR
    Haemostasis; 1979; 8(3-5):340-52. PubMed ID: 511014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of very low versus standard dose acetyl salicylic acid, dipyridamole and sulfinpyrazone on platelet function and thromboxane formation in man.
    Lorenz R; Siess W; Weber PC
    Eur J Pharmacol; 1981 Apr; 70(4):511-8. PubMed ID: 7238575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro evaluation of inhibitors of platelet release and aggregation.
    Rosenberg JC; Sell TL
    Arch Surg; 1975 Aug; 110(8):980-3. PubMed ID: 168838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New specialties, registered in Austria. Anturane 200 mg dragees, regulator of platelet function].
    Wien Klin Wochenschr; 1979 Nov; 91(22):771-4. PubMed ID: 516749
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of Anturane and aspirin on thrombocyte aggregation].
    Ciko Z; Stanimirović D
    Vojnosanit Pregl; 1984; 41(5):341-5. PubMed ID: 6516242
    [No Abstract]   [Full Text] [Related]  

  • 13. A study of the relationship between ex vivo and in vivo effects of sulphinpyrazone in the guinea pig.
    Butler KD; Wallis RB; White AM
    Haemostasis; 1979; 8(3-5):353-60. PubMed ID: 159853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the inhibitory action of prostaglandin E1 on platelet aggregation in rats: a study with ticlopidine, aspirin, dipyridamole and sulfinpyrazone.
    Tuong CC; Ferrand C; Aubert D; Loubrie JC; Tuong A
    Biochem Pharmacol; 1982 Mar; 31(6):1147-50. PubMed ID: 7200772
    [No Abstract]   [Full Text] [Related]  

  • 15. [Sulfinpyrazone and aspirin in experimental microthrombosis].
    Villaverde CA; Hernández MR; Escolar G; Almirall L; Borruel MT
    Arch Farmacol Toxicol; 1981 Apr; 7(1):7-10. PubMed ID: 7325718
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological properties of drug inhibiting platelet aggregation.
    de Gaetano G
    Acta Clin Belg; 1975; 30(3):184-9. PubMed ID: 1231456
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of antithrombotic drugs ex vivo and in vivo.
    Buchanan M; Hirsh J
    Bibl Anat; 1977; (16 Pt 2):208-11. PubMed ID: 603518
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of in vitro platelet aggregation and its inhibition by three antithrombotic drugs between human and guinea pig.
    Huang ZS; Lee TK
    Proc Natl Sci Counc Repub China B; 1991 Feb; 15(1):8-14. PubMed ID: 1946813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of platelet function inhibitors on experimental venous thrombosis formation in rabbits.
    Arfors KE; Bergqvist D; Tangen O
    Acta Chir Scand; 1975; 141(1):40-2. PubMed ID: 1092111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfinpyrazone and aspirin increase epicardial coronary collateral flow in dogs.
    Davenport N; Goldstein RE; Capurro N; Lipson LC; Bonow RO; Shulman NR; Epstein SE
    Am J Cardiol; 1981 Apr; 47(4):848-54. PubMed ID: 7211699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.